Skip to main content
Clinical Trials/CTRI/2022/10/046581
CTRI/2022/10/046581
Completed
未知

Salivary and Gingival Crevicular fluid Levels of NLRP3 in patients diagnosed with Symptomatic Irreversible Pulpitis- A Case Control Study.

DAX ABRAHAM0 sites32 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
DAX ABRAHAM
Enrollment
32
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 21, 2023
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
DAX ABRAHAM

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for Group 1 (healthy individuals)
  • a) Patients age 18\-40 years of age
  • b) Patients with no relevant medical history or absence of any systemic conditions
  • c) Non\-smokers
  • d) OHI index of 0 and Russel’s Periodontal index (not \>0\.9\)
  • Inclusion Criteria for Group 2 (Experimental Group)
  • a) Patients with carious teeth diagnosed as Symptomatic irreversible pulpitis and Heft Parker Scale reading more than 54\.
  • b) Patients with no relevant medical history or absence of any systemic conditions
  • c) OHI index of 0 and Russel’s Periodontal index (not \>0\.9\)

Exclusion Criteria

  • a) Patients with systemic condition or medical illness
  • b) Patients with periodontitis (Russel’s periodontal Index score \> 0\.9\)

Outcomes

Primary Outcomes

Not specified

Similar Trials